It has been two and a half years since the emergence of the SARS-CoV-2 virus and the COVID-19 outbreak. Despite the success of safe and efficacious vaccines for COVID-19, people still fall ill due to viral infection and the ensuing complications. With the continual emergence of SARS-CoV-2 variants of interest, the threat is far from over. In this webinar, Lianghui (Lucy) Zhang and Michael Cobas Meyer will discuss strategies employed by scientists to develop effective therapies for COVID-19.
Topics to be covered
Speakers
Lianghui (Lucy) Zhang, MD, PhD
Assistant Professor
Department of Pharmacology & Regeneration
University of Illinois at Chicago
Michael Cobas Meyer, MD
Vice President
Neuroscience Pain Early and Late Phase Development and Lilly Research Laboratories COVID-19 Therapies
Eli Lilly and Company
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy